ICON Public Limited Company (ICLR)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Barry Balfe
|
CEO & Director | 985k | -- | 1979 |
|
Dr. John Climax Ph.D.
|
Founder & Independent Non-Executive Director | 100k | -- | 1953 |
|
Mr. Nigel Clerkin A.C.A.
|
Chief Financial Officer | 741k | -- | 1974 |
|
Mr. Steve Empoliti
|
Chief Commercial Officer | 2.51M | -- | -- |
|
Lyons Emer
|
Chief Accounting Officer | -- | -- | -- |
|
Mr. Thomas N. O'Leary
|
Chief Information Officer | -- | -- | -- |
|
Mr. Diarmaid Cunningham
|
Chief Administrative Officer, General Counsel & Company Secretary | -- | -- | 1975 |
|
Ms. Niamh Murphy
|
Director of Corporate Communications | -- | -- | -- |
|
Mr. David Green
|
Vice President of Marketing | -- | -- | -- |
|
Mr. Joe Cronin
|
Chief Human Resources Officer | -- | -- | -- |
ICON Public Limited Company
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 40,200
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Corporate Governance
Upcoming Events
October 27, 2026 at 8:00 PM UTC
ICON Public Limited Company Earnings Date
